Sinomenine Hydrochloride Activates Podocyte Autophagy by Attenuating PI3K/AKT/mTOR Pathways to Protect Diabetic Nephropathy
Journal of Biochemical and Molecular Toxicology · 2025
DOI: 10.1002/jbt.70455 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biochemical and Molecular Toxicology, 2025. Verfasst von Lihan Xie und 3 weiteren Autor:innen. Beteiligte Einrichtung: College of Traditional Chinese Medicine, Hubei University of Chinese Medicine, Wuhan, Hubei, China. Hauptthemen laut MEDLINE: Podocytes, Autophagy, Morphinans, Proto-Oncogene Proteins c-akt. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: This study was supported by Chen Xiaoping Foundation for The Development of Science and Technology of Hubei Province (CXPJJH122001-2240), Institute of Basic Th….
Abstract (Originalsprache)
Diabetic kidney disease (DKD) is a common complication of diabetes, often characterized by podocyte injury, proteinuria, and eventual renal failure. Sinomenine hydrochloride (SH), an active component derived from traditional Chinese medicine, is clinically effective in treating kidney diseases. This study investigates the protective effects of SH on podocytes under high‐glucose conditions and its mechanism of action. Mouse podocytes (MPC‐5) were treated with SH at concentrations of 50, 200, and 600 μg/mL under high‐glucose conditions (30 mmol/L) for 24 h to establish a DKD model. Cell viability was assessed using CCK‐8 assays, and apoptosis rates were measured using flow cytometry. Autophagy levels were evaluated by detecting LC3‐II, Beclin‐1, and P62 proteins via Western blot analysis, while the involvement of the PI3K/AKT/mTOR pathway was analyzed by examining phosphorylated AKT and mTOR. Transmission electron microscopy was employed to observe autophagosomes. SH improved podocyte viability, reduced apoptosis, and enhanced autophagic activity by increasing LC3‐II and Beclin‐1 expression while decreasing P62 levels. SH also downregulated p‐AKT and p‐mTOR, indicating inhibition of the PI3K/AKT/mTOR pathway. Electron microscopy confirmed increased autophagosomes in SH‐treated groups. SH protects podocytes in a high‐glucose environment by enhancing autophagy through inhibition of the PI3K/AKT/mTOR pathway. These findings provide insights into SH as a potential therapeutic agent for DKD management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Traditional Chinese Medicine, Hubei University of Chinese Medicine, Wuhan, Hubei, China.
- Department of Nephrology, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
- Nephrology Department, Hubei Provincial Hospital of Traditional Chinese Medicine, Wuhan, Hubei, China.
- Nephrology Department, Hubei Provincial Traditional Chinese Medicine Research Institute, Wuhan, Hubei, China.
- Nephrology Department, Hubei University of Chinese Medicine Affiliated hospital, Wuhan, Hubei, China.
- Hubei Shizhen Laboratory, Wuhan, Hubei, China.
ORCID-Profile: Jinsong Jin
Förderung
- This study was supported by Chen Xiaoping Foundation for The Development of Science and Technology of Hubei Province (CXPJJH122001-2240), Institute of Basic Th…
Zitieren
APA
Xie, L., Li, W., Fan, S., & Jin, J. (2025). Sinomenine Hydrochloride Activates Podocyte Autophagy by Attenuating PI3K/AKT/mTOR Pathways to Protect Diabetic Nephropathy. Journal of Biochemical and Molecular Toxicology. https://doi.org/10.1002/jbt.70455
Vancouver
Xie L, Li W, Fan S, Jin J. Sinomenine Hydrochloride Activates Podocyte Autophagy by Attenuating PI3K/AKT/mTOR Pathways to Protect Diabetic Nephropathy. Journal of Biochemical and Molecular Toxicology. 2025. doi:10.1002/jbt.70455
BibTeX
@article{Xie2025,
author = {Xie, Lihan and Li, Weinan and Fan, Shiqi and Jin, Jinsong},
title = {Sinomenine Hydrochloride Activates Podocyte Autophagy by Attenuating PI3K/AKT/mTOR Pathways to Protect Diabetic Nephropathy},
journal = {Journal of Biochemical and Molecular Toxicology},
year = {2025},
doi = {10.1002/jbt.70455}
}
EUVIMED